Monday, December 14, 2009

Did you get my invite?


Add Friend Request from Tubely.com for a_baalbaki Abdallah Baalbaki wants to be your friend

a_baalbaki
Do you want to add Abdallah Baalbaki to your friends network ?
 
Click here to accept a_baalbaki as a friend
Accept
   Click here to reject friend request
Reject
Privacy Policy  Unsubscribe  Terms and Conditions

Tuesday, June 16, 2009

ABDALLAH BAALBAKI has sent you this Mippin

A message from your friend ABDALLAH BAALBAKI


Drug slows early stage arthritis
by BBC News | Health | World Edition

A drug reserved for advanced rheumatoid arthritis can prevent disability if used earlier, research suggests.


abdallah has sent you this Mippin

A message from your friend abdallah


Men warned of greater cancer risk
by BBC Health



The reluctance of men to adopt a healthy lifestyle and visit the doctor may be fuelling a gender gap in cancer cases and deaths, experts say.

Among cancers which affect both sexes, men are 60% more likely to develop the disease and 70% more likely to die from it, Cancer Research UK said.

There is no known biological reason for this but it may be because women take better care of themselves, they said.

Experts said men needed to be made aware of the risks they faced.



abdallah has sent you this Mippin

A message from your friend abdallah


Chronic asthma study offers hope
by BBC Health



Scientists believe they have discovered a key component in the development of chronic asthma, pointing the way to new treatments.

As asthma progresses, the airways are changed or remodelled and become more muscular and reactive to allergens.

Critical to this process is a cellular pump in the muscles called SERCA2, Proceedings of the National Academy of Sciences reports.

Ultimately drugs acting on SERCA2 might stop lung damage, the UK experts hope.



Monday, June 15, 2009

abdallah has sent you this Mippin

A message from your friend abdallah


Iran's Leader Emerges With Stronger Hand
by NYT: Latest News



TEHRAN - The jokes among Mahmoud Ahmadinejad's detractors are legion. In one, he looks in the mirror and says, "Male lice to the right, female lice to the left." In the West, one American tabloid rarely misses a chance to refer to him as "Evil Madman" and in the days before his re-election here he was taunted as a "monkey" and as a "midget."

But the Mahmoud Ahmadinejad who was announced winner of a second four-year term this week is no cartoon character.

Whether his 63 percent victory is truly the will of the people or the result of fraud, it demonstrated that Mr. Ahmadinejad is the shrewd and ruthless front man for a clerical, military and political elite that is more unified and emboldened than at any time since the 1979 revolution.

As president, Mr. Ahmadinejad is subordinate to the country's true authority, Supreme Leader Ayatollah Ali Khamenei, who commands final say over all matters of state and faith. With this election, Mr. Khamenei and his protégé appear to have neutralized for now the reform forces that they saw as a threat to their power, political analysts said.

"This will change the face of the Islamic Republic forever," said one well-connected Iranian, who like most of those interviewed declined to be named in the current tense climate. "Ahmadinejad will claim an absolute mandate, meaning he has no need to compromise."

When he was first elected president in 2005, Mr. Ahmadinejad showed his fealty to the leader, gently bending over and kissing his hand.

On Saturday, the leader demonstrated his own enthusiasm for the re-elected president, hailing the outcome as "a divine blessing" even before the official three-day challenge period had passed. On Sunday, Mr. Ahmadinejad flaunted his achievement by mounting a celebration rally in the heart of an opposition neighborhood of Tehran, and holding a victory news conference where he scorned the West and made a joke out of his main opponent's quasi-house arrest.

Commenting on the Obama administration's conciliatory overtures, he also suggested that his willingness to reconcile with foreign governments would depend on their willingness to swallow his disputed election.

Asked about speculation that in his second term he would take a more moderate line, he smirked, "It's not true. I'm going to be more and more solid."

He can afford to be. With the backing of the supreme leader and the military establishment, he has marginalized all of the major figures who represented a challenge to the vision of Iran as a permanently revolutionary Islamic state.

In many ways, his victory is the latest and perhaps final clash in a battle for power and influence that has lasted decades between Mr. Khamenei and Ali Akbar Hashemi Rafsanjani, the former president who, while loyal to the Islamic form of government, wanted a more pragmatic approach to the economy, international relations and social conditions at home.

Mr. Rafsanjani aligned himself and his family closely with the main reform candidate in this race, Mir Hussein Moussavi, a former prime minister who advocated greater freedom - in particular, greater freedom for women - and a more conciliatory face to the West. Another former president and pragmatist, Mohammed Khatami, had also thrown in heavily with Mr. Moussavi.

The three men, combined with widespread public support and disillusionment with Mr. Ahmadinejad, posed a challenge to the authority of the supreme leader and his allies, political analysts said.

The elite Revolutionary Guards and a good part of the intelligence services "feel very much threatened by the reformist movement," said a political analyst who asked not to be identified for fear of retribution. "They feel that the reformists will open up to the West and be lenient on the nuclear issue," he said. "It is a confrontation of two ways of thinking, the revolutionary and the internationalist. It is a question of power."

Since the vote was announced Saturday, Mr. Moussavi has been the hero of seething antigovernment protests in Tehran, but so far they have been contained by legions of riot police officers and hampered by a shutdown of that critical organizing tool, text-messaging. Mr. Moussavi said he was being "closely monitored" in his home, but hoped to speak at a rally on Monday.

"He ran a red light, and he got a traffic ticket," Mr. Ahmadinejad quipped when asked about his rival.

Unless the street protests achieve unexpected momentum, the election could cast the pro-reform classes - especially the better off and better educated - back into a state of passive disillusionment, some opposition figures said.

"I don't think the middle class is ever going to go out and vote again," one Moussavi supporter lamented.

When he first caught the West's attention, Mr. Ahmadinejad had been plucked from an obscure provincial governorship and made mayor of Tehran. There he established himself as a promising populist politician. He refused to use the mayor's big car or occupy the mayor's grand office. He didn't accept his salary.

Four years ago, the supreme leader anointed him as the fundamentalist presidential alternative to two candidates the leader thought less reliable, Mr. Rafsanjani and Mehdi Karroubi, a former speaker of Parliament. (Mr. Karroubi, a reformist cleric, tried again in this election, and on Friday was humiliated by the announcement that he had come in fifth in a field of four - after the invalidated ballots.)

Although his first election was marred by allegations of cheating, Mr. Ahmadinejad was credited with being genuinely street smart. He roused crowds with vague attacks on the corruption of the elite, with promises of a vast redistribution of wealth, and with appeals to Iranian pride. By playing to the Muslim world's feelings of victimization by the West and hatred of Israel, he won adulation on the Arab street even as Arab leaders often disdained him, and that in turn earned him credibility at home.

"The old generation of the Islamic Revolution was going to die off," said one Iranian analyst. "We thought they would inevitably give way to the reformers. But they found Ahmadinejad, and he was a wise choice. He was a new breed of populist - a new breed of demagogue."

He is the son of an iron worker, a traffic engineer by education, but political analysts said that he might have been molded most by his experience in the Revolutionary Guards.

As president he has presided over a time of rising inflation and unemployment, but has pumped oil revenues into the budget, sustaining a semblance of growth and buying good will among civil servants, the military and the retired.

More important, he has consolidated the various arms of power that answer ultimately to the supreme leader. The Revolutionary Guards - the military elite - was given license to expand into new areas, including the oil industry and other businesses such as shipbuilding.

The Guardian Council, which oversees elections, had its budget increased 15-fold under Mr. Ahmadinejad. The council has presided over not only Friday's outcome, but over parliamentary majorities loyal to Mr. Ahmadinejad.

For a time, it appeared that he was losing the favor of the supreme leader. Under Mr. Ahmadinejad, Iran was hit with sanctions by the United Nations Security Council, inflation and unemployment soared and unrest was rising at home as social restrictions were increased. Two of his own ministers quit, criticizing his management of the state, and Parliament discussed the prospect of impeachment.

The president seemed to stumble often. He raised tensions with the West when he told a United Nations General Assembly that he rejected the post-World War II order. He was mocked when he said at Columbia University in 2007 that there was not a single gay person in Iran. In April, nearly two dozen diplomats from the European Union walked out of a conference in Geneva after he disparaged Israel.

But political analysts said that back home, the supreme leader approved, seeing confrontation with the West as helpful in keeping alive his revolutionary ideology, and his base of power. President Obama's conciliatory tone toward Iran, some Iranians believe, threatened to relax Iranian vigilance and the powerful forces to defend it.

Mr. Obama has made clear he still intends to explore an opening to Iran, though the questions of Mr. Ahmadinejad's legitimacy and the consolidation of hard-line power could complicate his strategy.

"The coming period will not be an easy one," said Gamal Abdel Gawad, director of the international relations section at the Ahram Center for Political and Strategic Studies in Cairo. "Any change will be slow and difficult because we have an elite that is very much united in its hard-line orientation."



abdallah has sent you this Mippin

A message from your friend abdallah
read


Iran protester slain after huge pro-reform rally (AP)
by Yahoo! Top Stories



AP - Gunfire from a compound used by pro-government militia killed one demonstrator Monday after hundreds of thousands of opponents of President Mahmoud Ahmadinejad massed in central Tehran to cheer their pro-reform leader in his first public appearance since elections that he alleges were marred by fraud.



Sunday, June 14, 2009

Drugmakers rush to produce a swine flu vaccine

baalbaki59@gmail.com has sent you a Pocket Express News Article

Drugmakers rush to produce a swine flu vaccine

LONDON - With swine flu now an official pandemic, the race is on among drugmakers to produce a vaccine.

GlaxoSmithKline said Thursday after the World Health Organization declared a global flu epidemic that it would be ready within weeks to begin large-scale vaccine production. Sanofi-Aventis also said it had started working on its own version. On Friday, Swiss pharma giant Novartis announced it had created an experimental vaccine that has not been tested in people. Novartis' vaccine was made via a cell-based technology that may prove faster than the traditional way of making vaccines, which relies on chicken eggs.

Many rich countries like Britain, Canada and France signed contracts with pharmaceuticals long ago, guaranteeing them access to pandemic vaccine. WHO and others estimate that about 2.4 billion doses of pandemic vaccine could be available in about a year.

The likely scramble for vaccines will leave many people in poorer countries empty-handed.

So far, swine flu has been mostly detected in developed countries like the United States, Europe, Japan and Australia.

"We do not know how this virus will behave under conditions typically found in the developing world," WHO chief Dr. Margaret Chan said Thursday. She said the agency expects to see a "bleaker" picture as the virus makes its way to Africa and Asia.

WHO spokesman Gregory Hartl said officials were concerned people in poorer countries and those fighting other health problems like malaria, tuberculosis, malnutrition and pneumonia might be more susceptible to swine flu.

On Friday, WHO said that 74 countries had reported nearly 30,000 cases including 145 deaths. But so far, the virus appears to be mild. Most people don't need medical treatment to get better.

But the virus might have a more devastating effect in people with underlying health problems. About half of the people who have died from swine flu have had complications like asthma, diabetes, and obesity.

"Any population that has health challenges is potentially going to be at higher risk with H1N1 (swine flu)," Hartl said.

In May, officials led by Chan and U.N. Secretary General Ban Ki-moon asked vaccine makers to save a portion of their production for poor countries. Chan was aiming to get 10 percent of the global pandemic vaccine supply reserved for poor nations.

Some companies have agreed to help. GlaxoSmithKline PLC offered to donate 50 million doses of pandemic vaccine to WHO for distribution to developing countries.

During the bird flu crisis, Sanofi-Aventis promised WHO about 60 million doses based on the H5N1 strain. WHO is now talking with Sanofi to switch some or all of those vaccines over to swine flu doses.

Because more than 95 percent of flu vaccines are still made in eggs, experts say the Novartis announcement is unlikely to significantly boost the world's pandemic vaccine supply.

But the news pushed up Novartis shares by 4.4 percent to close at 45 Swiss francs ($41.84) on the Zurich exchange Friday.

WHO


This information sent to you from Pocket Express®. Download FREE Pocket Express for your mobile phone - free news, sports, weather, travel and more: http://www.pocketexpress.eu/downloadexpress.php?f= 96170928212 or visit http://pexp.mobi/gp.php?f= 96170928212 to install directly from your phone!

Thursday, June 11, 2009

Study suggests drug is safe for morning sickness (AP)

WidSets

Your friend baalbaki59@gmail.com wanted to inform you about the following

""

Study suggests drug is safe for morning sickness (AP)

AP - For the first time, a large study shows that pregnant women who suffer morning sickness are not risking harm to their babies if they take a certain anti-nausea drug. The result may lead more doctors to prescribe the drug metoclopramide and women to feel less guilty about using it during their baby's crucial first few months of development, experts said.

Read the full story from http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/ap/us_med_morning_sickness_drug.html »

Already a WidSets user? Pick this widget. | Interested in stuff like this? Become a WidSets user. It's free!

This message was sent from your friend's mobile widget. http://www.widsets.com/

Attached file sent via Quickaccess.

Tuesday, June 9, 2009

ذكر أم أنثى؟ بواسطة فحص لبول الأم الحامل

WidSets

Your friend baalbaki59@gmail.com wanted to inform you about the following

""

ذكر أم أنثى؟ بواسطة فحص لبول الأم الحامل

في غضون عشر دقائق من إجراء فحص البول، أصبح بإمكان المرأة الحامل تحديد جنس الجنين وما إذا ذكراً أو أنثى.. فإذا كان اللون أخضر فهذا يعني أنه ذكر، وإذا كان برتقالياً، فهو يعني أنه أنثى.

Read the full story from http://arabic.cnn.com/2009/scitech/6/9/gender.test/index.html »

Already a WidSets user? Pick this widget. | Interested in stuff like this? Become a WidSets user. It's free!

This message was sent from your friend's mobile widget. http://www.widsets.com/

WHO Recommends Rotavirus Vaccine for All Children

WidSets

Your friend baalbaki59@gmail.com wanted to inform you about the following

""

WHO Recommends Rotavirus Vaccine for All Children

The World Health Organisation recommended on Friday that oral rotavirus vaccines be included in all national immunization programs to avert half a million diarrheal deaths and 2 million hospitalizations a year.
Reuters Health Information

Read the full story from http://www.medscape.com/viewarticle/703972?src=rss »

Already a WidSets user? Pick this widget. | Interested in stuff like this? Become a WidSets user. It's free!

This message was sent from your friend's mobile widget. http://www.widsets.com/

Sunday, May 24, 2009

Blepharitis

WidSets

Your friend baalbaki59@gmail.com wanted to inform you about the following

""

Blepharitis

Blepharitis: Inflammation of the eyelids.

Blepharitis occurs in two forms, anterior and posterior:

*

Anterior blepharitis affects the outside front of the eyelid, where the eyelashes are attached. The two most common causes of anterior blepharitis are bacteria (Staphylococcus) and scalp dandruff.

*

Posterior blepharitis affects the inner eyelid (the moist part that makes contact with the eye) and is caused by problems with the oil (meibomian) glands in this part of the eyelid. Two skin disorders can cause this form of blepharitis: rosacea and seborrheic dermatitis

of the scalp (scalp dandruff).

Both types of blepharitis can cause a foreign body or burning sensation, excessive tearing, itching, sensitivity to light (photophobia), red and swollen eyelids, redness of the eye, blurred vision, frothy tears, dry eye, or crusting of the eyelashes on awakening. Complications from blepharitis include:

*

Stye: A red tender bump on the eyelid that is caused by an acute infection of the oil glands of the eyelid.

*

Chalazion: This condition can follow the development of a stye. It is a usually painless firm lump caused by inflammation of the oil glands of the eyelid. Chalazion can be painful and red if there is also an infection.

*

Problems with the tear film: Abnormal or decreased oil secretions that are part of the tear film

can result in excess tearing or dry eye. Because tears are necessary to keep

the cornea healthy, tear film problems can make people more at risk for

corneal infections.

Treatment for both forms of blepharitis involves keeping the lids clean and free of crusts. Warm compresses should be applied to the lid to loosen the crusts, followed by a light scrubbing of the eyelid with a cotton swab and a mixture of water and baby shampoo. Because blepharitis rarely goes away completely, most patients must maintain an eyelid hygiene routine for life. If the blepharitis is severe, an eye care professional may also prescribe antibiotics or steroid eyedrops.

When scalp dandruff is present, a dandruff shampoo for the hair is recommended as well. In addition to the warm compresses, patients with posterior blepharitis will need to massage their eyelids to clean the oil accumulated in the glands. Patients who also have acne rosacea should have that condition treated at the same time.

MedTerms (TM) is the Medical Dictionary of MedicineNet.com.
We Bring Doctors' Knowledge To You

Read the full story from http://www.medterms.com/guide.asp?s=rss&k=WordOfTheDay&a=22450 »

Already a WidSets user? Pick this widget. | Interested in stuff like this? Become a WidSets user. It's free!

This message was sent from your friend's mobile widget. http://www.widsets.com/

Wednesday, May 20, 2009

FW: Rocket Fuel Chemical Found in Infant Formula

April 2009

Top 10 Most Read Articles by Pediatricians:
  1. Rocket Fuel Chemical Found in Infant Formula  
CDC scientists find perchlorate in samples of powdered infant formula.
  2. A 5-Year-Old Boy With an Abnormal Left Eye  
  3. Adenoidectomy and Tonsillectomy Linked to Subsequent Overweight in Children  
  4. Clinical Assessment of the Crying Infant Should Guide Decision Making  
  5. US Declares Swine Flu Emergency  
  6. Cephalosporin Use in Treatment of Patients With Penicillin Allergies  
  7. Presentation, Prognosis, Treatment of Most Common Newborn Rashes Reviewed  
  8. Parenting Practices and ADHD  
  9. AHA Updates Advice on Strep Throat, Preventing Rheumatic Fever  
10. Pacifier Use May Not Adversely Affect Breast-Feeding Duration or Exclusivity  

Top 10 Most Read Articles by All Physicians:

  1. Efalizumab Withdrawn From US Market  
Efalizumab (Raptiva), used for the treatment of psoriasis, will no longer be available in the United States because of the risk for progressive multifocal leukoencephalopathy.
  2. Hidden Malpractice Dangers in EMRs  
  3. The Case of the Missing Shaving Blade!  
  4. US Declares Swine Flu Emergency  
  5. Stimulus Package Could Convert More Physicians to EHRs  
  6. Dealing with the "Disruptive" Physician Colleague  
  7. A 5-Year-Old Boy With an Abnormal Left Eye  
  8. Progressive Neurologic Deterioration in a 23-Year-Old Man  
  9. WHO Raises Pandemic Level for Swine Flu, Mexican Death Toll Mounts  
10. Less Is More: Simplified 4-Step Algorithm Improves BP Control  

» Update your email address

» Contact MedPulse Editors

» Contact Technical Support

» Opt out of this newsletter

» Opt out of all Medscape mailing lists

» Not yet a Medscape member?

» Forgot your login info?

» Need additional support?

   Medscape from WebMD
   Email Newsletters
   111 Eighth Avenue
   New York, NY 10011
Medscape from WebMD
Baalbaki MD.

-original message-
Subject: Rocket Fuel Chemical Found in Infant Formula
From: "Medscape Top 10" <TopTen@mp.medscape.com>
Date: 19/05/2009 8:59 pm